Brief: Entera Bio Provides Financial Results For The Third Quarter Of 2022
10/11/2022 21:42
Nov 10 (Reuters) - Entera Bio Ltd 5DT.F :
* ENTERA BIO PROVIDES CORPORATE UPDATES AND FINANCIAL
RESULTS FOR
THE THIRD QUARTER OF 2022
* ENTERA BIO LTD QTRLY LOSS PER SHARE $0.11
Source text for Eikon: ID:nGNX9j2YXc
Further company coverage: 5DT.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entera Bio
See all newsBrief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation
Corrected: Israel's Entera Bio Q2 net loss widens
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement